%20(1).jpg)
Discover the association
PSCC Connect is a non-profit association (French law of 1901) whose mission is to bring together all the economic players contributing to the PSCC and the oncology community. Thanks to its extensive network and regular meetings, PSCC Connect offers players in the PSCC economic ecosystem a platform for convergence, collaboration and co-creation.
The role of PSCC Connect:
-
Represent the PSCC's economic players and gather their needs and ideas,
-
Promote PSCC initiatives within this ecosystem,
-
Facilitate interaction between members.
All players in the economic ecosystem wishing to contribute to innovation in the fight against cancer are welcome to join PSCC Connect. This includes oncology players from start-ups to major corporations, as well as innovation partners such as CROs (Clinical Research Organizations), service and technology companies. We also invite local institutions such as local authorities, competitiveness clusters, incubators, chambers of commerce and, of course, healthcare investors to join us.
+ 170
members
« Join PSCC Connect now and help build what will become a unique community, entirely dedicated to innovation in oncology, whatever the technology. By combining our strengths and dreams, our talents and expertise, doing our best to collaborate and bringing all our energy to bear, we will accelerate innovation in the fight against cancer, for the benefit of patients. »
Christian Deleuze, PSCC Connect President
The association's colleges
Large companies
Bristol-Myers Squibb GSK Servier Ipsen Johnson & Johnson Merck Sanofi Takeda Board representatives : Christian Deleuze (Sanofi) Nathalie Depreville (Servier) Catherine George (Ipsen) Philippe Jacquot (Takeda)
SMEs
Abbelight Abcely Adlin Science AI4bio Algenscribe Altevax Apmonia Therapeutics Aqemia Ardan Pharma ASQII Biocytex Blue Bees Therapeutics Brenus Pharma Celeos Cherry Biotech Cure51 Cyberna Cytea bio Emglev Therapeutics e-miRgency ErVimmune EverImmune Exosome Analytics Fasten Genexpath Gliocure GMT Science Hephaïstos pharma Hippoxis Imaginostics, Inc. Infocus Innate Pharma IntegraGen IterOnco Mabqi Magic Genomix McSAF Mnemo Therapeutics MPC Therapeutics MSInsight Neolys-Diagnostics NeoVentures Biotechnology Europe Newteam Medical NK Diagnostics Occlugel Odimma-Therapeutics Okomera On/Off Therapeutics Oncodesign Precision Medicine Onconex Remunity Therapeutics One Biosciences Orakl Oncology Oranomed Orinova Owkin OWL Lifesciences Pegascy Pepkon Persea Proimaging Promontory Therapeutics Proskope Prostperia Qalita Quniten Health Robeauté Rosetta Omics See2cure Serendip innovations SmartCatch Sur'Touch Telomium Theranovir Theraonco Therapanacea Therasonic Yomi Board representatives : Stéphanie Cornen (Innate Pharma) Nathalie Donne (Ervimmune) Quentin Lubart (Abbelight) Wahid Awad (Rosetta Omics)
ETI Institutions
Calym CCI du Val-de-Marne Etablissement Public d'Aménagement Paris Saclay France Biotech Grand-Orly Seine Bièvre Institut Polytechnique de Paris Matwin Medicen Paris Region Paris Est Marne et Bois Fondation PSCC Wilco Board representatives : Etienne Lonchamp (Medicen) Lucia Robert (Matwin)
Research support companies
ACROBiosystems Affinisep Agile Capital Markets Agilent Technologies Alhena Consult Alter Ego biotech Antineo Ariana Pharma AxiomHealth Capital Innovation B2G Life Sciences Berthelot DDC Biodeigma Biogael consulting Biognosys Biophact Bio-Techne Biotem Capital Cell Cell'Ectiv CKD Pharma Consulting CliniSciences Diverchim Dlog consulting ERBC Group Explicyte Fidal Firalis Molecular Precision GxP Quality Services HMC Matching Hologic diagenode Icosa ILife Consulting Illumina Inferential Inits JCBioconsultEU JPT Peptide Technologies Kadans Keyrus KYomed Innov Lab2Biotech Lavoix Leads To Development Lipomize Maxcyte Merck Life Sciences Mission Bio Myriagone Conseil New England Biolabs Novaxia Nuvisan Oncodesign services Oncofactory Parean Biotechnologies Pearl Biosystem Phinc PL-Conseil Promega France Qualees RD-Biotech Seqalis Simbec-Orion skepsos Sphere Bio Stilla Technologies Tebubio SAS Therawings consulting Thermo Fisher Scientific ULTRace Development Partner Voxcan XenTech Board representatives : Marina Iche (ILife Consulting) Amaury Lachaud (Biognosys)
Investors
Andera Partners Angels Santé Bioqube Ventures Bpifrance G Ventures JEITO Capital Sofinnova Partners Technofounders Board representatives : Julien Elric (Jeito) Stéphane Loze (Angel Santé)
